CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...